Cite

HARVARD Citation

    Zhao, Y. et al. (2017). AZD0530 sensitizes drug‐resistant ALK‐positive lung cancer cells by inhibiting SRC signaling. FEBS open bio. 7 (4), pp. 472-476. [Online]. 
  
Back to record